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A B S T R A C T
Purpose: The characteristics of electrographic seizures in newborns with hypoxic-ischaemic encepha-
lopathy (HIE) treated with therapeutic hypothermia (TH) are poorly described. This retrospective,
observational study provides reference data on the characteristics of seizures and their evolution over
time in newborns with HIE receiving whole-body TH.
Method: The cohort under analysis included 23 infants with HIE and seizures deﬁned by multi-channel
EEG recordings. Clinical presentation, details of TH and antiepileptic drugs used were recorded. Time
from ﬁrst to last-recorded electrographic seizure (seizure period) was calculated. Temporal
characteristics of seizures – total burden, duration, number, burden in minutes per hour, distribution
of burden over time (temporal evolution), time from seizure onset to maximum seizure burden (Tmsb), T1,
and time from Tmsb to seizure offset, T2 – were analysed.
Results: The median age at electrographic seizure onset was 13.1 h (IQR: 11.4 to 22.0). Tmsb was reached
at a median age of 19.4 hours (IQR: 12.2 to 29.7). Median seizure period was 16.5 h (IQR: 7.0 to 49.7),
median number of seizures per hour was 1.9 (IQR: 1.0 to 3.3). The seizure burden was 4.0 min/h (IQR: 2.0 to
7.0). There was no consistent pattern in the temporal evolution of seizures in neonates treated with TH. The
skewness was neither positive nor negative (p-value = 0.15), there was no difference between the duration
of T1 and T2 (p-value = 0.09) and no difference in the seizure burden between T1 and T2 (p = 0.09).
There was an association between Tmsb and Phenobarbital (PB) administration (r = 0.76, p-
value < 0.001).
Conclusion: There is no consistent temporal evolution of seizure burden in neonates treated with TH.
Seizures are diffuse, and their characteristics are variable.
 2015 Published by Elsevier Ltd on behalf of British Epilepsy Association.
Contents lists available at ScienceDirect
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The outcome of neonatal encephalopathy secondary to birth
asphyxia has been improved by therapeutic hypothermia (TH)
[2,3,12]. The precise mechanism through which TH exerts its effect
is unclear; however, its role in neuroprotection is probably
multifactorial [17,38].
Seizures occur in moderate and severe hypoxic ischemic
encephalopathy (HIE) [21,29]. The temporal distribution of theseAbbreviations: TH, Therapeutic hypothermia; PB, Phenobarbital; HIE, hypoxic-
ischaemic encephalopathy; AED, anti-epileptic drug.
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1059-1311/ 2015 Published by Elsevier Ltd on behalf of British Epilepsy Association.seizures is not uniform, with a short period of high electrographic
seizure burden followed by a longer period of low seizure burden,
resulting in an accumulation of seizures near the time of seizure
onset (a positive skew) [23]. Seizures in human newborns with HIE
may exacerbate the initial hypoxic ischemic injury [1,14,25].
Neonatal seizures are difﬁcult to control, and studies performed
before the widespread use of TH show that traditional ﬁrst and
second line anti-epileptic drugs (AEDs) are often ineffective [7,40].
There is emerging evidence that TH reduces overall seizure
burden and may contribute to improved neurodevelopmental
outcome [22,32,33]. The mechanisms through which TH exerts an
anti-epileptic effect are unclear. Hypothermia has been shown to
suppress the release of glutamate in animal models thus reducing
excitotoxicity [8,18]. TH may also enhance the anti-epileptic effect
of phenobarbital (PB). There is conﬂicting evidence regarding
changes in pharmacokinetics due to the administration of PB in
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the background EEG have been observed [37].
The temporal characteristics of electrographic seizures in
normothermic infants with HIE have been well described
[9,23,31]. Low et al., compared the differences in overall
electrographic seizure burden between normothermic and hypo-
thermic infants [22]. There are relatively few studies which
investigate in detail the temporal characteristics of electrographic
seizure burden in newborns with HIE treated with TH. Studies have
described the age of seizure onset in newborns with HIE who
receive TH and illustrated that the age of electrographic seizure
onset is variable in these infants [15,39]. However, these studies
lacked details on the distribution of electrographic seizures over
time (temporal evolution), such as number of seizures per hour,
seizure burden per hour, and measures of how seizures change
over time. Description of these characteristics is important as it
adds to the understanding of the impact of TH on seizures in HIE
and provides a benchmark against which the efﬁcacy of new anti-
seizure treatments can be assessed in the context of emerging new
therapies, in the era of ‘Therapeutic Hypothermia Plus’.
The aim of this study was to investigate the temporal
characteristics of seizures i.e. seizure period (the period between
ﬁrst and last recorded electrographic seizure), number of seizures
per hour, seizure burden per hour and the temporal evolution of
seizures in newborns with HIE receiving whole-body TH and
standard AED therapy.
2. Materials and methods
2.1. Population
Infants with acute HIE treated with TH were enrolled for
continuous video EEG monitoring studies in the neonatal intensive
care units (NICU) of Cork University Maternity Hospital (CUMH)
and University College London Hospitals (UCLH). All EEG research
studies are conducted with approval from the Clinical Research
Ethics Committee of the Cork Teaching Hospitals, Ireland, and the
National Health Service in the UK, via the Integrated Research
Application Service. Parental written, informed consent was
obtained for all newborns recruited for EEG monitoring studies.
Newborns were cooled according to the entry criteria and
guidelines set by the UK Total Body Hypothermia for Neonatal
Encephalopathy (TOBY) cooling registry [36]. A clinical grade of
encephalopathy was assigned to infants using the modiﬁed Sarnat
score at 24 h of age [21]. Infants with electrographic seizures were
included in this retrospective study if they were term (>37 weeks
gestation), had HIE ( 2 of the following criteria: initial arterial or
capillary pH <7.1, Apgar score <6 at 5 min, a continued need for
resuscitation after birth, clinical evidence of encephalopathy), had
no complicating illness such as meningitis, were treated with TH
within 6 h of birth and underwent continuous video EEG
monitoring from within 12 h of birth.
2.2. EEG recordings
EEG recording methods were identical in both hospitals. EEG
electrodes were applied to the scalp at F3, F4, C3, C4, T3, T4, O1, O2,
and CZ (according to the international 10–20 system of electrode
placement, as modiﬁed for neonates). P3 and P4 electrodes were
also applied whenever possible. NicOne EEG monitors (CareFusion
NeuroCare, Middleton, Wisconsin, USA) were used to record
continuous video-EEG recordings for approximately 96 h. Record-
ings commenced as soon as possible after birth. Bilateral amplitude
integrated EEG (aEEG) traces were displayed simultaneously from
the right and left fronto-central regions (F4-C4 and F3-C3) and
used by neonatologists as an aid to clinical decision making. Themulti-channel EEG recordings were analysed and annotated
retrospectively.
2.3. Anti-epileptic drug treatment
First line AED treatment was identical in both centres with
infants receiving 20 mg/kg of phenobarbital intravenously (IV) for
clinically suspected seizures or seizures detected on aEEG or EEG.
Clinicians did not have continuous access to the interpretation of
the EEG by the neonatal neurophysiologist which was performed
post-hoc. Unresponsive or recurrent seizures were treated with an
additional dose of Phenobarbital 10 mg/kg IV. The second line AED
in CUMH was phenytoin and midazolam in UCLH. Neonates
received regular maintenance doses of AEDs on completion of each
loading dose. Levels of AEDs were not measured in all neonates in
the cohort.
2.4. Data acquisition and analysis
The medical records of each infant were reviewed. Clinical
presentation, duration of TH, types of AED, dose and time of
administration were noted. A response to AED was deﬁned as a
complete cessation of seizures for at least 12 h after AED
administration.
An electrographic seizure was deﬁned as repetitive rhythmic
activity of greater than 10 s duration, with a distinct beginning,
middle and end [10]. All electrographic seizures were annotated
from the start of each seizure on any channel to the end of the
seizure on any channel. Seizures were annotated by two
experienced neonatal neurophysiologists and agreed by consen-
sus. Inter-observer agreement for seizure detection based on the
visual interpretation of multi-channel EEG has been shown to be
high [34]. Seizure annotations were converted into a time series,
where 1 represented the presence of a seizure and 0 the absence of
a seizure. This time series was sampled at 1 Hz. The seizure
annotation time series was then cropped between the start of the
ﬁrst recorded EEG seizure and the end of the last recorded EEG
seizure. The length of this period was recorded (seizure period).
Total seizure burden was deﬁned as the accumulated duration, in
minutes, of all seizures recorded in each infant during EEG
monitoring [10,23]. To further investigate the temporal evolution
of seizure burden, the seizure annotation time series of each
newborn was then segmented into two periods; the time between
the ﬁrst recorded seizure and the maximum seizure burden (T1),
and the time between the maximum seizure burden and the last
recorded seizure (T2). The time of maximum seizure burden (Tmsb)
was deﬁned as the mid-point of an hour long window shifted in
time by 1s across the full EEG recording that contained the
maximum duration of seizure. Within these two periods, the
seizure burden per hour, the seizure duration and number of
seizures per hour were measured. All measures of the seizure
characteristics were based on the annotation of the EEG by the
neonatal neurophysiologist.
2.5. Statistical analysis
Continuous data were described using the median, the inter-
quartile range (IQR), minimum and maximum values. The
symmetry of the temporal evolution of seizure burden was
described using the skewness coefﬁcient. The one-sample Wil-
coxon Signed Rank Test (compared to a population median of 0)
was used to test if the symmetry was signiﬁcantly different to that
of a uniform distribution (which has a skewness coefﬁcient = 0). A
positive skewness coefﬁcient indicates accumulation of seizures
near the beginning of the seizure period. Differences between time
periods (T1 and T2) were tested using the Sign Test, and differences
Table 1
Clinical characteristics of neonates included in the study (n = 23) Data are
median (interquartile range) or n.
Gestational Age (weeks) 40.6 (39.8 to 41.6)
Birth Weight (Kg) 3525 (3190 to 3947)
Gender (M:F) 11:12
Clinical HIE Score
Moderate: Severe 13:10
5 min Apgar score 4 (2 to 5)
First pH a 6.8 (6.7 to 7.0)
Base Excess (mEq/L) b 21.6 (23.5 to 11.4)
a n = 18.
b n = 17.
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Mann-Whitney U test. The strength of the association between two
continuous variables was measured using Pearson’s correlation
coefﬁcient. All statistical analyses were performed using PASW
Statistics 18. All tests were two-sided and a p-value <0.05 was
considered to be statistically signiﬁcant.
3. Results
3.1. Patient population
From August 2009 to July 2011, in CUMH and UCL, 43 newborns
with moderate or severe HIE were recruited for continuous EEG
studies. Both centres used identical criteria for identiﬁcation of
HIE, and the same EEG monitoring techniques. Of the 43 infants
with HIE, 23 who received TH developed electrographic EEG
seizures and were eligible for inclusion. 15 of these 23 infants were
included in a previous study by [22]. 13 infants had moderate HIE
(grade 2) and 10 had severe HIE (grade 3). Clinical characteristics
are described in Table 1. Four infants had an instrumental delivery
(vacuum or forceps), 10 were delivered by emergency caesarean
section, and 9 had vertex vaginal deliveries, of whom 3 had
shoulder dystocia. All 23 required resuscitation at birth and were
eligible for TH under the TOBY criteria. None of the infants
developed sepsis, severe electrolyte disturbances or hypoglycae-
mia during the monitoring period.Fig. 1. A graphical representation of the seizure time series combined with clinical inf
duration of therapeutic hypothermia is marked by a horizontal blue line. Annotated seizu
administration is denoted by a series of vertical coloured lines: Phenobarbital – red; phe
burden (peak in seizure burden) is denoted by a blue cross. Infants are ordered in termInfants received TH for a median of 72.0 h (IQR: 66.8 to 72.0). In
four infants cooling was discontinued early. Three of these infants
(babies 13, 19, 21 in Fig. 1) had severe HIE and a decision was made
to discontinue intensive care. One infant was rewarmed early
because of good clinical condition, had a single subsequent three
minute electrographic seizure and did not receive AEDs.
EEG monitoring was commenced at between 1.4 and 11.0 h of
age at a median age of 5.8 h (IQR: 4.1 to 9.1). EEG monitoring
continued for a median of 91.2 h (IQR: 78.0 to 129.0). Infants with
moderate HIE were monitored for a median of 87.9 h (IQR: 77.3 to
104.0) and those with severe HIE were monitored for a median of
107.6 h (IQR: 78.0 to 139.6). The duration of monitoring did not
differ signiﬁcantly with grade of HIE (p-value= 0.37). A total of
1581 seizures were recorded in 23 infants. Fig. 1 illustrates the
distribution of seizures in infants.
3.2. Electrographic seizure burden
Seizures continued over a median period of 16.5 h from ﬁrst
recorded seizure to last recorded seizure (IQR: 7.0 to 49.7) i.e. the
seizure period. The earliest time of seizure onset was 7.0 h and the
latest was 81.9 h. The median age at ﬁrst recorded seizure was
13.1 h (IQR: 11.4 to 22.0). The median age at which maximum
electrographic seizure burden (Tmsb) was reached was 19.4 h (IQR:
12.2 to 29.7). The median seizure burden per hour was 4.0 min/h
(IQR: 2.0 to 7.0). In 7 infants, the maximum seizure burden was in
excess of 30 min/h. This corresponds to a deﬁnition of neonatal
status epilepticus [20]. The median age at which the last
electrographic seizure was recorded was 37.2 h (IQR: 23.9 to
91.4).
The summary statistics for seizure burden in the 23 infants is
shown in Table 2. The skewness coefﬁcient was not signiﬁcantly
different from zero (p-value = 0.15; see Table 2). A positively
skewed temporal evolution was seen in infants with severe HIE
(median skewness coefﬁcient = 0.68 IQR: 0.31 to 1.39, p-val-
ue = 0.03). The median skewness coefﬁcient in infants with
moderate HIE was 0.00 (IQR: 0.59 to 0.40, p-value = 0.91).
Additional summary statistics for moderate and severe HIE are
shown in Table 3.ormation. The start and end of EEG monitoring are denoted by blue triangles. The
res are denoted by a vertical black line. Missing data are denoted by a red cross. AED
nytoin – green; midazolam – cyan; clonazepam – magenta. The maximum seizure
s of increasing seizure burden.
Table 2
Temporal characteristics of electrographic seizures overall with comparison between T1 and T2 (n = 23).
T1 + T2 T1 T2 p-value (from Sign test)
median IQR median IQR median IQR
Seizure Period (h) 16.5 7.0 to 49.7 2.5 0.5 to 7.4 10.9 3.9 to 38.2 0.09
Total Seizure Burden (min) 55 28 to 190 18 11 to 34 36 13 to 94 0.09
Total Seizure Number 26 13 to 86 9 2 to 14 14 4 to 66 0.007
Missing Data (%) 0 0 to 0.9 0.00 0 to 0 0.00 0 to 0 0.45
Seizure Burden (min/h) 4.0 2.0 to 7.0 9.1 4.4 to 22.8 4.1 1.5to 6.3 0.21
Mean Seizure Duration (s) 125 82 to 238 126 81 to 278 116 69 to 302 0.29
Number of Seizures (per h) 1.9 1.0 to 3.3 2.8 1.7 to 6.4 2.5 0.9 to 3.9 1.00
Skewnessa 0.35 0.32 to 0.85 – – – – 0.15a
a p-value = 0.15 from One-sample Wilcoxon Signed Rank Test
T1 is the time period between seizure onset and the time of maximum seizure burden
T2 is the time period between the time of maximum seizure burden and seizure offset
T1 + T2 is the time period between seizure onset and seizure offset.
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severe HIE (median 219 min, IQR: 60 to 289) compared with
moderate HIE (median 44 min, IQR: 24 to 62, p-value = 0.007). The
number of seizures per hour and the seizure burden per hour
were not signiﬁcantly different between moderate and severe HIE.
The seizure period and the duration of T2 were signiﬁcantly longer
in severe HIE (p-value = 0.02 and p-value = 0.03, respectively). The
seizure duration was trending towards a lower value in infants
with moderate HIE (p-value = 0.051).
3.3. Use of antiepileptic drugs
The use of AEDs was analyzed. AEDs were administered a total
57 times (PB; 38 times) in 22 infants. PB was the ﬁrst line AED in all
cases. AED administration was concurrent with EEG monitoring
49 times (PB; 30 times) in 21 infants. AEDs were administered within
the electrographic seizure period 36 times (PB; 24 times) in
16 infants. Of these, 30 administrations were in response to seizures
which had an EEG correlate (PB; 22 times). AEDs were administered
a total of 11 times (PB; 11 times) in 10 infants during T1.
PB was given to 10/23 infants prior to the ﬁrst recorded
electrographic seizures due to clinical concerns about seizures. In
7 of these infants PB was administered before EEG monitoring was
commenced. The 16/23 infants given PB during the electrographic
seizure period received it at a median age of 16.2 h (IQR: 12.6 to
25.4). In 11 of these 16 infants this was the ﬁrst dose of PB (20 mg/
kg). In ﬁve infants it was the second dose of PB (10 mg/kg – babies
9, 14, 15, 19 and 21 in Fig. 1). Of these 16 infants, 9 had moderate
HIE and 7 had severe HIE.Table 3
Subgroup analysis of the temporal characteristics of electrographic seizures overall wi
T1 + T2 T1
Median IQR Median 
Moderate (n = 13)
Seizure period(h) 14.6 4.6 to 21.0 2.5 
Seizure burden (min/h) 3.9 1.6 to 14.2 9.1 
Seizure duration (s) 176 91 to 302 203 
Seizure frequency (seizures/h) 1.2 0.7 to 2.5 2.1 
Skewness 0.00 0.59 to 0.40 
Severe (n = 10)
Seizure period (h) 48.1 12.2 to 99.5 4.6 
Seizure burden (min/h) 4.1 3.2 to 6.6 9.2 
Seizure duration (s) 87 79 to 142 92 
Seizure frequency (seizures/h) 2.9 1.4 to 3.7 4.7 
Skewness 0.68 0.31 to 1.39 
a p-value from One-sample Wilcoxon Signed Ranks Test.
T1 is the time period between seizure onset and the time of maximum seizure burden
T2 is the time period between the time of maximum seizure burden and seizure offset
T1 + T2 is the time period between seizure onset and seizure offset.In the 16 infants who received PB during the electrographic
seizure period, the time of PB administration was signiﬁcantly
correlated with Tmsb (r = 0.76, p-value < 0.001). The correlation
was inﬂuenced by infants with moderate HIE rather than severe
HIE (moderate; r = 0.95, p-value < 0.001, severe; r = 0.51, p-
value = 0.25, respectively). The relationship between time of PB
administration and Tmsb is shown in Fig. 2. In 6/9 infants with
moderate HIE who received a dose of PB during the seizure period,
seizures responded to PB treatment. The response rate was 1/7 in
infants with severe HIE (Fisher’s exact – p-value = 0.06).
Four infants received phenytoin as a second line AED, at a
median age of 27.3 h (IQR: 18.2 to 46.7). Seven infants received
midazolam as a second line AED, at a median age of 25.9 h (IQR:
14.7 to 34.3). Two infants received clonazepam as a third line
anticonvulsant. The number of infants receiving second line
anticonvulsants within the seizure period was too small to
estimate the correlation between time of administration and Tmsb.
4. Discussion
To our knowledge, this is the ﬁrst quantitative description of the
temporal characteristics of electrographic seizures in term new-
borns with HIE receiving TH, and the evolution of these
characteristics over time. It provides further reference data on
characteristics of electrographic seizures in HIE during TH: seizure
period, number of seizures per hour and seizure burden in minutes
per hour. It also provides data on the temporal evolution of these
characteristics i.e. distribution of seizure burden over time, time
from seizure onset to maximum seizure burden and time fromth comparison between T1 and T2.
T2 p-value (from Sign test)
IQR Median IQR
0.4 to 5.5 8.8 0.3 to 16.4 1.00
3.5 to 32.3 4.1 1.3 to 41.2 1.00
97 to 760 126 81 to 455 0.39
1.3 to 6.8 2.3 0.7 to 4.5 0.58
0.91 a
1.1 to 13.6 39.8 7.3to 52.8 0.02
8.4 to 12.9 3.9 1.9 to 6.1 0.11
78 to 129 86 60 to 151 0.75
2.3 to 6.3 2.7 1.2 to 3.7 0.34
0.03a
.
.
Fig. 2. The relationship between the time of PB administration and the time of
maximum electrographic seizure burden across 16 infants with moderate and
severe HIE who received PB during the seizure period. The administration of PB is
highly correlated with Tmsb suggesting that either clinical recognition of seizures
was associated with PB administration time or that PB administration was
interfering with any potential increase in seizure burden. This was the ﬁrst dose of
PB (20 mg/kg) in 11 infants (unﬁlled markers). It was the second dose (10 mg/kg) in
5 infants (ﬁlled markers).
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seizure characteristics of infants with moderate and severe HIE are
reported separately.
Our previous study demonstrated signiﬁcantly reduced total
seizure burden, and a trend towards lower mean seizure duration,
total seizure number and incidence of status epilepticus in
newborns with HIE receiving TH compared with normothermic
infants with HIE [22]. Our additional assessment of seizure
characteristics in an expanded cohort of 23 hypothermic infants
strengthens the evidence that hypothermic infants have a lower
seizure burden with a more temporally diffuse distribution of
seizures (a lower seizure burden per hour) than normothermic
infants.
As with our previous study [23], we focussed on the temporal as
opposed to the spatial characteristics of EEG seizures. Including a
spatial component in the analysis of seizure burden may lead to an
improved understanding of the effect of neuroprotective therapies
on seizure propagation within the neonatal brain. Future work
with a greater number of electrodes will enhance the analysis of
seizure burden [27].
The median seizure period in this cohort of infants was 16.2 h.
The median seizure period in the normothermic cohort we
previously described was 36.6 h [23]. Animal studies have also
shown shorter electrographic seizure duration and seizure period
in those receiving TH [35]. Electrographic seizure onset in this
cohort of infants receiving TH was at a median age of 13.1 h. The
latest age at electrographic seizure onset was 81.9 h. While only
one neonate appeared to have seizure onset during the period of
rewarming, we noticed several instances of seizure reoccurrence
during this period suggesting that the increase in metabolism
apparent at this time may trigger additional seizures [19]. This
wide range of age at seizure onset is comparable to existing studies
and coupled with more diffuse temporal distribution of seizures
means that detection of neonatal seizures in the context of TH may
prove difﬁcult in the absence of continuous long term EEG
monitoring [15,39].
In our cohort of neonates treated with TH, the duration of T1
does not differ from that of T2, nor does the seizure burden in thetwo time periods differ signiﬁcantly. This is in contrast to ﬁndings
in normothermic neonates where T2 was signiﬁcantly longer than
T1 and short term assessment of seizure burden was signiﬁcantly
higher in T1 compared to T2 [23]. In fact, the relationship between
the seizure burden in T1 and T2, while not signiﬁcant, was the
converse of that see in normothermic neonates. As the deﬁnitions
of T1 and T2 are dependent on the deﬁnition of Tmsb, we
hypothesize that Tmsb is occurring closer to seizure onset in
newborns treated with TH. This shift in Tmsb may be altering the
skew of the distribution of seizures over time (the temporal
evolution) in a signiﬁcant number of neonates and may result in a
shortened overall seizure period. Preliminary analysis of PB
administration suggests that it may be PB that is altering Tmsb
as Tmsb is highly correlated with PB administration time, a ﬁnding
that was not as apparent in our study of normothermic neonates
[23]. This suggests that our observations are not of the temporal
evolution of seizures in neonates treated with TH but rather the
temporal evolution of seizures in neonates treated with TH and
AEDs.
This alteration in Tmsbmay be due to a number of factors. Firstly,
the introduction of TH has had the added beneﬁt of more uniform
treatment and monitoring of infants with HIE [2]. Secondly,
improvements in early EEG or aEEG monitoring of newborns with
HIE resulting from the necessity to commence TH within six hours
of birth may result in better timing of PB administration. The
administration of PB appears to be given earlier in our cohort of
neonates treated with TH compared to our cohort of normothermic
neonates [23], although differences have not been statistically
analysed. Timing of PB administration has been shown, in animal
studies, to be an important factor in the efﬁcacy of PB, with early
administration proving more effective than administration once
seizures are well established [4,11,26]. Finally, TH alters the way
PB effects the evolution of background EEG [37], and it is possible
that its efﬁcacy is enhanced in the altered milieu of TH.
The role of PB in seizure reduction in the TH cohort is largely
conﬁned to infants with moderate HIE. The correlation between
Tmsb and time of PB administration reaches overall signiﬁcance
because of the correlation in the moderate subgroup (r = 0.95, p-
value < 0.001). Low et al. identiﬁed the most signiﬁcant reduction
in seizure burden during TH amongst infants with moderate HIE. In
this expanded cohort of 23 infants total seizure burden is
signiﬁcantly higher in those with severe HIE compared with
moderate HIE (p-value = 0.007). The overall beneﬁts of TH have
been found to be greater in infants with moderate HIE ([2,12,42]). A
response rate to PB in hypothermic infants similar to that observed
in our study has been reported by [15] with 30% of infants with
moderate/severe injury responding to a single dose of PB compared
with 100% of those with minimal/no injury evident on MRI.
This study was retrospective and observational and describes
the temporal characteristics and temporal evolution of electro-
graphic seizures in infants receiving TH. For this reason, the
principle reference time point in this study was the time of
electrographic seizure onset, which was reliably recorded due to
the early application of continuous EEG monitoring. Future
prospective work using continuous EEG, in addition to the use
of MRI and investigating perinatal events, may help to establish a
relationship between the nature and timing of brain injury and the
temporal evolution of neonatal seizures [5,30].
Not all infants in this cohort received TH for a full 72 h. Three
infants with severe HIE and one with moderate HIE had TH
withdrawn. However, we have included them in this cohort as
their exclusion would have led to an over-representation of infants
with moderate HIE.
Further work is required to investigate the response to
conventional and novel forms of AED treatment in HIE in the
context of therapeutic hypothermia. Only larger studies across
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to characterise the response to PB in infants with HIE [28].
5. Conclusions
The aim of this study was to describe the temporal character-
istics and evolution of electrographic seizures in infants with HIE
who received TH. Our results contribute new information
regarding seizure period, number of seizures per hour and seizure
burden per hour in these infants. This cohort differed from the
normorthermic cohort we previously described in that we did not
identify a consistent positively skewed temporal evolution across
the entire group [23]. We found a signiﬁcant correlation between
Tmsb and PB administration suggesting that we were not describing
the temporal evolution of seizure in neonates treated with TH but
rather neonates treated with TH and AEDs.
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